Michael Holzel
Michael Holzel
Institute of Experimental Oncology, University Hospital Bonn, Germany. Twitter: @IEO_HolzelLab
Overená e-mailová adresa na: ukb.uni-bonn.de
Názov
Citované v
Citované v
Rok
Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma
T Bald, T Quast, J Landsberg, M Rogava, N Glodde, D Lopez-Ramos, ...
Nature 507 (7490), 109-113, 2014
4432014
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
J Landsberg, J Kohlmeyer, M Renn, T Bald, M Rogava, M Cron, M Fatho, ...
Nature 490 (7420), 412-416, 2012
4152012
MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling
S Huang, M Hölzel, T Knijnenburg, A Schlicker, P Roepman, U McDermott, ...
Cell 151 (5), 937-950, 2012
3652012
The transcriptional program of a human B cell line in response to Myc
M Schuhmacher, F Kohlhuber, M Hölzel, C Kaiser, H Burtscher, M Jarsch, ...
Nucleic acids research 29 (2), 397-406, 2001
3412001
Chemotherapeutic drugs inhibit ribosome biogenesis at various levels
K Burger, B Mühl, T Harasim, M Rohrmoser, A Malamoussi, M Orban, ...
Journal of Biological Chemistry 285 (16), 12416-12425, 2010
3012010
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
Y Gao, F Souza-Fonseca-Guimaraes, T Bald, SS Ng, A Young, SF Ngiow, ...
Nature immunology 18 (9), 1004-1015, 2017
2392017
Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?
M Hölzel, A Bovier, T Tüting
Nature Reviews Cancer 13 (5), 365-376, 2013
2232013
Stringent doxycycline-dependent control of gene activities using an episomal one-vector system
GW Bornkamm, C Berens, C Kuklik-Roos, JM Bechet, G Laux, J Bachl, ...
Nucleic acids research 33 (16), e137-e137, 2005
1942005
Immune cell–poor melanomas benefit from PD-1 blockade after targeted type I IFN activation
T Bald, J Landsberg, D Lopez-Ramos, M Renn, N Glodde, P Jansen, ...
Cancer discovery 4 (6), 674-687, 2014
1852014
The experimental power of FR900359 to study Gq-regulated biological processes
R Schrage, AL Schmitz, E Gaffal, S Annala, S Kehraus, D Wenzel, ...
Nature communications 6 (1), 1-17, 2015
1842015
ALK mutations conferring differential resistance to structurally diverse ALK inhibitors
JM Heuckmann, M Hölzel, ML Sos, S Heynck, H Balke-Want, M Koker, ...
Clinical Cancer Research 17 (23), 7394-7401, 2011
1762011
A role for c‐Myc in the regulation of ribosomal RNA processing
I Schlosser, M Hölzel, M Mürnseer, H Burtscher, UH Weidle, D Eick
Nucleic acids research 31 (21), 6148-6156, 2003
1762003
NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome
M Hölzel, S Huang, J Koster, I Øra, A Lakeman, H Caron, W Nijkamp, ...
Cell 142 (2), 218-229, 2010
1732010
Mammalian WDR12 is a novel member of the Pes1–Bop1 complex and is required for ribosome biogenesis and cell proliferation
M Hölzel, M Rohrmoser, M Schlee, T Grimm, T Harasim, A Malamoussi, ...
The Journal of cell biology 170 (3), 367-378, 2005
1662005
IL-36γ (IL-1F9) is a biomarker for psoriasis skin lesions
AM D'erme, D Wilsmann-Theis, J Wagenpfeil, M Hölzel, S Ferring-Schmitt, ...
Journal of Investigative Dermatology 135 (4), 1025-1032, 2015
1512015
ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome
S Huang, J Laoukili, MT Epping, J Koster, M Hölzel, BA Westerman, ...
Cancer cell 15 (4), 328-340, 2009
1342009
Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma
P Falletta, L Sanchez-del-Campo, J Chauhan, M Effern, A Kenyon, ...
Genes & development 31 (1), 18-33, 2017
1322017
Interdependence of Pes1, Bop1, and WDR12 controls nucleolar localization and assembly of the PeBoW complex required for maturation of the 60S ribosomal subunit
M Rohrmoser, M Hölzel, T Grimm, A Malamoussi, T Harasim, M Orban, ...
Molecular and cellular biology 27 (10), 3682-3694, 2007
1272007
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment
S Riesenberg, A Groetchen, R Siddaway, T Bald, J Reinhardt, D Smorra, ...
Nature communications 6 (1), 1-16, 2015
1072015
Reactive neutrophil responses dependent on the receptor tyrosine kinase c-MET limit cancer immunotherapy
N Glodde, T Bald, D van den Boorn-Konijnenberg, K Nakamura, ...
Immunity 47 (4), 789-802. e9, 2017
1032017
Systém momentálne nemôže vykonať operáciu. Skúste to neskôr.
Články 1–20